Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01777867 · ClinicalTrials.gov registry record
Cough Reflex Sensitivity and Bronchial Hyper-responsiveness
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 24
- Enrollment target
NCT01777867: Completed study, sponsored by Mayo Clinic.
NCT01777867 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01777867 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The aim of this study is to provide pilot data on the possible gastrointestinal predictors of respiratory hyper-responsiveness and how these relate to the clinical sub-types of gastroesophageal reflux disease (GERD) and visceral acid hypersensitivity.
Interventions
- PROCEDURE Methacholine Challenge
- PROCEDURE Cough Reflex Sensitivity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-02 |
What the finished NCT01777867 record still lists
NCT01777867 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Methacholine Challenge is the first listed.
NCT01777867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01777867 about?
NCT01777867 is a clinical study titled "Cough Reflex Sensitivity and Bronchial Hyper-responsiveness". The aim of this study is to provide pilot data on the possible gastrointestinal predictors of respiratory hyper-responsiveness and how these relate to the clinical sub-types of gastroesophageal reflux disease (GERD) and visceral acid hypersensitivity.
What is the current status of trial NCT01777867?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2012-12. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01777867?
The interventions under investigation include: Methacholine Challenge (PROCEDURE), Cough Reflex Sensitivity (PROCEDURE).
Who is sponsoring clinical trial NCT01777867?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia